Plain-English translation of NCT06274047 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a medication called to see if it can help reduce fatigue and improve quality of life in men with prostate cancer who have had surgery and now need additional radiation and hormone therapy. The trial will compare used alone or in combination with standard hormone therapy, depending on how aggressive your cancer is. Researchers want to understand whether this medication helps men feel less tired and maintain better overall health during treatment.
After prostate removal surgery, some men still have signs of cancer and need additional treatment with radiation and hormone therapy, which can cause significant fatigue and affect quality of life. This trial is trying to find out whether the new treatment can reduce these side effects while keeping cancer under control.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of four treatment groups based on how aggressive your cancer is. Some men will receive the new medication for 6 months alongside radiation and hormone therapy, while others will receive standard hormone therapy alone or for a longer period. Throughout the study, you'll complete questionnaires about fatigue, quality of life, mood, sleep, and physical activity, and you may wear a health tracking band. You'll also have regular blood work and doctor visits to monitor your progress and any side effects, with follow-up lasting up to 24 months depending on your assigned group.
AI-generated summary from trial data · Aug 4, 2026 · Not medical advice
United States